PPARγ-mediated advanced glycation end products regulate neural stem cell proliferation but not neural differentiation through the BDNF-CREB pathway.

Shao-hua Wang,Yi-jing Guo,Yang Yuan,Ling Li,Feng-fei Li,Kuan-ping Ye,Yan Huang
DOI: https://doi.org/10.1016/j.toxlet.2011.07.026
IF: 4.271
2011-01-01
Toxicology Letters
Abstract:Aims: To investigate the roles of PPAR gamma in advanced glycation end product (AGE)-mediated characteristics of neural stem cells (NSCs) and the molecular mechanisms of action. Methods: We prepared pLentiLox3.7 lentiviral vectors expressing short hairpin RNA (shRNA) against PPAR gamma and transduced NSCs. MTT absorbance and cell counts were used to assay cell growth, and cell differentiation was analysed by confocal laser-scanning and western blots for the expression of MAP2/nestin. The protein and gene expression of the BDNF CREB pathway components were examined by western blotting and real-time PCR. Results: Immunoblot analysis indicated that shRNA delivered by lentiviral vectors silenced PPAR gamma expression in NSCs. The proliferation of NSCs and expression of BDNF pathway components dropped in AGE-BSA culture medium (400 mg/L and 200 mg/L) on Day 3 and Day 7, respectively (all P<0.001). PPAR gamma-silenced NSCs exhibited a significant increase in cell growth and expression of BDNF pathway components compared with NSCs incubated with AGE-BSA (all P<0.001). Immunocytochemistry and western blotting analysis showed that AGE-BSA (400 mg/L) induced a significant decrease in the expression of MAP2 both in NSCs and PPAR gamma-silenced NSCs, as standardised by nestin. There was no significant difference between NSCs and PPAR gamma-silenced NSCs in the presence of AGE-BSA. Conclusions: PPAR gamma plays roles in the AGE-mediated regulation of NSC proliferation but not neural differentiation through the BDNF-CREB pathway. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
What problem does this paper attempt to address?